Perkins Coie Trust Company’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6
| Closed | -$39 | – | 300 |
|
|
2023
Q4 | $39 | Hold |
6
| – | – | ﹤0.01% | 295 |
|
|
2023
Q3 | $53 | Hold |
6
| – | – | ﹤0.01% | 606 |
|
|
2023
Q2 | $124 | Hold |
6
| – | – | ﹤0.01% | 228 |
|
|
2023
Q1 | $158 | Hold |
6
| – | – | ﹤0.01% | 236 |
|
|
2022
Q4 | $208 | Hold |
6
| – | – | ﹤0.01% | 226 |
|
|
2022
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 233 |
|
|
2022
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 231 |
|
|
2022
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 234 |
|
|
2021
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 226 |
|
|
2021
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 275 |
|
|
2021
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 277 |
|
|
2021
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 233 |
|
|
2020
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 242 |
|
|
2020
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 244 |
|
|
2020
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 250 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 325 |
|
|
2019
Q4 | $3K | Hold |
6
| – | – | ﹤0.01% | 274 |
|
|
2019
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 300 |
|
|
2019
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 302 |
|
|
2019
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 296 |
|
|
2018
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 290 |
|
|
2018
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 291 |
|
|
2018
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 294 |
|
|
2018
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 294 |
|
|
2017
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 287 |
|
|
2017
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 292 |
|
|
2017
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 299 |
|
|
2017
Q1 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 282 |
|